The Due Diligence Presentation That Almost Killed a £50M Deal (And the 3 Slides That Saved It)

The biotech company had done everything right. Twelve months of preparation. A data room that ran to 4,000 pages. A management team that could answer any question the acquirer threw at them.

Their due diligence presentation was 54 slides.

On slide 11, the lead partner from the acquiring firm put down his pen. “We need to stop,” he said. “I’m still waiting to understand what you actually want us to know.”

The deal didn’t die in the room. But it came close.

I’ve sat in a lot of due diligence rooms. On both sides. And the pattern is almost always the same.

The presenting company arrives with a deck that answers every question an acquirer might ask — in the order that felt logical to the team that built it. Market overview. Competitive landscape. Product roadmap. Financial history. Management team. Growth projections. Risk factors. Regulatory environment.

The acquirer’s team arrives with a very short list of questions. Not 54 slides worth. Usually three to five things they need to believe before they’ll proceed.

The mismatch is the problem. The presenting team is answering questions that weren’t asked. The acquirer is waiting for answers to questions that aren’t coming. By slide 20, the room has lost the thread. The acquirer’s attention has shifted to their own notes. The management team is presenting into a vacuum.

The biotech company I mentioned almost lost a £50M acquisition this way. What saved it wasn’t better data. It was rebuilding three slides — and understanding why those three, in that order, are the only slides that actually matter in a due diligence presentation.

Why Most Due Diligence Presentations Fail

The failure is almost never about the quality of the business. It’s about the structure of the argument.

Most due diligence presentations are built by finance teams and lawyers who are trained to be comprehensive. Comprehensive is correct for a data room. It is the wrong instinct for a live presentation to an acquisition team.

Acquirers in a due diligence meeting are not reading. They are deciding. Their question isn’t “have you answered every question?” Their question is: “Should we keep moving?” Those are fundamentally different questions — and they require fundamentally different slide structures.

When a presentation doesn’t answer the “should we keep moving?” question fast enough, three things happen. The acquirer’s team starts asking clarifying questions earlier than expected. The presenting team interprets questions as scepticism and adds more detail. The room bogs down in specifics before the core argument has landed. That’s when a partner puts their pen down and says, “I’m still waiting to understand what you actually want us to know.”

Slide 1: The Deal Rationale Anchor

The first thing an acquisition team needs to see isn’t your financials. It’s the strategic logic. Why does this deal make sense — for them?

Most presenting companies build a market overview slide first. The acquirer already knows the market. They’re in it. What they don’t know yet is: why this company, why now, and what they’d get that they can’t easily build themselves.

The Deal Rationale slide answers those three questions in 90 seconds. It should contain: the strategic gap the acquisition fills for the acquirer, the core capability or asset being acquired (one sentence, not a feature list), and the timing argument (why the window is now, not in two years). That’s it. No company history. No founding story. No market size graphic with a hockey stick.

The biotech company’s original deck opened with a 7-slide company overview. The acquirer’s team had read the IM. They already knew the overview. They were waiting for the deal rationale. When we moved the deal rationale to slide 2 (after a one-slide executive summary), the room shifted. The lead partner picked up his pen.

Slide 2: The Value Story

After deal rationale comes the value story — and this is where most presentations overcomplicate things.

The value story is not a financial model. It’s not a revenue bridge or a scenario analysis. Those live in the data room. The value story slide has one job: make the acquirer believe the value is real and accessible.

There are three components to a strong value story in due diligence: the headline number (the value created or to be realised), the proof point (the evidence that makes the number credible — a comparable transaction, a customer contract, a market share figure), and the access mechanism (what happens post-acquisition to unlock it — integration pathway, team retention, IP transfer).

Where presenting teams go wrong is building financial detail without giving the acquirer the narrative to interpret it. A revenue graph without a proof point is just a claim. A growth projection without an access mechanism is just optimism. The value story slide should be the narrative spine that makes the financial model believable — not a replacement for it.

For the biotech deal, the value story had been buried inside a 12-slide financials section. When we extracted it into a single slide with those three components — headline number, proof point (a signed licensing agreement worth £8M in year one), and access mechanism (the key relationship that came with the acquisition, not just the IP) — the acquirer’s team stopped asking sceptical questions and started asking integration questions. That’s the shift you’re looking for.

Slide 3: The Risk Map (The One Nobody Wants to Show)

Most due diligence presentations treat risk like a legal disclosure. They bury it at the back. They minimise it. They qualify everything.

That’s exactly the wrong approach — and acquirers know it.

An acquirer doing due diligence is actively looking for what you’re not showing them. If your risk section looks sanitised, they don’t feel reassured. They feel suspicious. They start digging harder. That’s when due diligence drags into month four and deals fall apart.

The Risk Map slide does the opposite. It puts the three to five most material risks on the table — clearly, with specifics. Not “regulatory risk” as a bullet point, but “EU regulatory approval for the lead compound requires a Phase 3 trial estimated at 18 months.” Then, for each risk: what you’ve already done to mitigate it.

This slide has a counterintuitive effect in the room. When an acquirer sees that you’ve identified the real risks and have mitigation plans in place, their confidence goes up — not down. They’re buying a management team as much as an asset. A team that knows its own risks and has thought through the responses is a team they want to own.

For the biotech company, this was the hardest slide to get agreement on. The finance team wanted to soften it. What went in was specific: three risks, with ownership, timelines, and mitigations. The lead partner read it carefully and then said, “This is the most honest risk page I’ve seen this year.” They moved to term sheet within three weeks.

If you’re preparing for a due diligence presentation, you might also find this article useful: Investor Pitch Deck Template — it covers the structural overlap between an investor deck and a DD presentation, and where the two formats diverge.

What Goes to the Appendix (and What Stays Out)

Once you have the three anchor slides — Deal Rationale, Value Story, Risk Map — everything else needs a test before it goes in the main deck.

The test: does this slide help the acquirer decide, or does it help the acquirer verify? If it’s verification material — detailed financial models, product roadmap timelines, team CVs, customer case studies — it belongs in the appendix. If it’s decision material — why this deal, why now, why you — it belongs in the main deck.

Acquirers will ask for appendix material when they need it. They will not dig for decision material buried on slide 38. Front-load the decision content. Let the appendix absorb everything else.

The practical rule: your main deck should not exceed 15 slides. The biotech company’s 54-slide deck restructured to 11 slides and an appendix of 43. The acquirer said they got more out of the 11-slide version than they had from an hour with the original deck.

For a deeper look at how decision-first structure works across different executive scenarios, see: Decision Slide That Gets Yes — the same structural principle applied to internal approvals.

PAA: Quick Answers on Due Diligence Presentations

How long should a due diligence presentation be?
A live due diligence presentation should be 10–15 slides in the main deck, with supporting material in the appendix. The goal is to answer the acquirer’s key decision questions — why this deal, why now, where is the value — before going into detail. Anything beyond 15 slides in the main deck means the structure hasn’t been resolved. Move verification material to the appendix.

What slides must be in a due diligence presentation?
Three slides anchor every effective due diligence deck: a Deal Rationale slide (strategic logic for the acquirer), a Value Story slide (where the value is, with proof), and a Risk Map slide (material risks with mitigations already in place). These three answer the only question that matters at this stage: should we keep moving?

Why do acquirers stop reading due diligence decks?
Usually because the deck is structured to answer the presenting company’s questions rather than the acquirer’s. Acquirers want to know: does this deal make strategic sense? Is the value real? What are the material risks? When those answers are buried behind market overviews and company history, attention drops. Put the decision material first.

If you recognised your last deal room in any of the above, the structure isn’t the hard part — it’s having the right templates to implement it quickly under time pressure. That’s what the Executive Slide System is built for.

Free: Investor Pitch Deck Checklist — the pre-presentation structure review for high-stakes investor and M&A meetings.

Also published today: if the presentation itself isn’t the problem but the physical symptoms of nerves are, read When Public Speaking Fear Becomes a Medical Emergency. And if you’re facing Q&A from executives who like to test hypotheticals, The Hypothetical Trap covers exactly that.